INTRODUCTION
CBFβ is a transcription factor that forms heterodimeric complexes with members of the CBFα family of proteins 1 . The α-subunit includes three family members, each encoded by a unique gene: CBFA1 (RUNX2, AML3, PEBP2αA), CBFA2 (RUNX1, AML1, PEBP2αB) and CBFA3 (RUNX3, AML2, PEBP2αC). CBFA1 is required for osteoblast differentiation and bone formation; CBFA2 is required for hematopoiesis; the function of CBFA3 is currently unknown [2] [3] [4] [5] [6] [7] [8] . The genes are related by virtue of the highly conserved Runt domain, which is responsible for binding DNA and interacting with Cbfβ 9 . CBFβ is encoded by a single gene, CBFB. It stabilizes the flexible C-terminal loop of the Runt domain (CBFα) that interacts with the minor groove of DNA 10 , resulting in a complex that is a more potent transcription factor than CBFα alone 11, 12 .
Although CBFβ interacts with all three Cbfα family members in vitro, mouse models have only shown evidence for a role for Cbfβ in hematopoiesis. In mouse embryos, there are two stages of hematopoiesis: primitive and definitive 13 . The yolk sac is the major site for the generation of primitive hematopoietic cells, which include nucleated red blood cells and primitive macrophages. Primitive erythrocytes are found in the yolk sac beginning at 7 days post-coitus (dpc). Definitive hematopoietic cells, which
give rise to mature lineages commonly found in adults, originate in the yolk sac, paraaortic splanchnopleura and in hematopoietic clusters of the aorta-gonad-mesonephros (AGM). By 11 dpc, the fetal liver becomes the major site for definitive hematopoiesis.
Homozygous Cbfb knock-out (Cbfb -/-) mice die during mid-gestation from severe hemorrhages throughout the embryo 14, 15 . Definitive hematopoiesis is completely absent
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The crucial role of the CBF complex in hematopoiesis is underscored by the observation that CBFB or CBFA2 are targeted by chromosomal rearrangements in nearly 30% of acute myeloid leukemia (AML) 16 . The primary chromosomal rearrangement involving CBFB is inv(16)(p13q22). Inv(16) is associated with almost all cases of AML subtype M4 Eo and results in the fusion of CBFB with MYH11, the gene for smooth muscle myosin heavy chain 17 . Previously, we used a knock-in strategy to generate a mouse model in which Cbfb-MYH11 is expressed under the control of the endogenous mouse Cbfb gene 18 .
Chimeric mice derived from ES cells targeted with the knock-in
Cbfb-MYH11 gene were used to assess the leukemogenic potential of the fusion gene 19 .
Although the Cbfb-MYH11 knock-in chimeras did not develop leukemia naturally in the first year of life, most of the animals developed AML within 3-5 months after treatment with the chemical mutagen, N-ethyl-N-nitroso-urea (ENU). The dose of ENU used was not sufficient to induce leukemia in wild type chimeras. The leukemia in the Cbfb-MYH11 chimeras was characterized by the presence of myelomonocytic blasts and occasional eosinophils, very similar to patients with AML M4 Eo. These observations suggested that while expression of Cbfb-MYH11 is not sufficient for leukemogenesis, it is a necessary event in the multi-step process that gives rise to inv(16)-associated leukemias.
Analysis of the contribution of ES cells with the Cbfb-MYH11 knock-in gene in chimeric animals provided evidence that Cbfb-MYH11 blocks differentiation of the 20, 21 . It also inhibited CBFα2-mediated transactivation, and has been shown to increase CBFα2-mediated repression 21, 22 . Together, these data provide evidence that expression of Cbfb-MYH11 blocks hematopoietic differentiation in a dominant negative manner by inhibiting the normal function of CBF.
Considering the critical role of Cbfb in normal hematopoiesis and leukemogenesis it is important to further characterize its expression in different hematopoietic cell populations. Previous studies indicated that Cbfb is expressed in the central nervous system, cranial nerve and dorsal root ganglia, eyes, limb bud, somites and ribs of mouse embryos, as assessed by in situ hybridization 1, 14 . In adults, Cbfb expression is considered to be ubiquitous since it has been detected in most adult tissues and various cell lines by Northern blot analysis 11, 12 . In this paper we characterize the expression of Cbfb in embryonic and adult hematopoietic tissues and dissect the specific hematopoietic defects associated with CBFB-MYH11 expression, using a newly created Cbfb-GFP knock-in mouse model. 
MATERIALS AND METHODS

Generation of Cbfb-GFP knock-in mice
The targeting construct was assembled in the plasmid vector, pPNT-Hygro, which includes the positive selection marker, hygromycin, expressed under control of the SV40 promoter. The vector also includes the HSV thymidine kinase gene expressed from the pgk promoter for negative selection. 
Genotype Analysis
The presence of Cbfb-GFP was analyzed by PCR from DNA isolated from tail biopsies, or yolk sac. Fifty nanograms of template DNA were amplified by PCR using primers specific for hygromycin (hygro forward 5' CCATCGTCGAGATCCAGACATG 3' and hygro reverse 5' GTATATGCTCCGCATTGGTCTTG 3'). To distinguish heterozygotes from homozygotes, primers detecting the wild type, but not the targeted allele were used (intron 4 forward 5' ATAAGCAGCAAATAGGTAGAGTG 3' and mC5 reverse 5' GACCTGTCTCTATCCTCAAATTC 3'). The PCR samples were initially 
Western Blot Analysis
Lysates from adult tissues or ES cells were prepared by resuspending 1X10 6 cells in NuPage LDS sample buffer with reducing agent (Invitrogen, Carlsbad, CA) and boiling the samples for 15 min. The proteins were separated by electrophoresis on NuPage 4-12% bis-tris gels in MES running buffer and transferred onto nitrocellulose membranes using the semi-dry blotting system (Amersham, Piscataway, NJ).
Membranes were probed with a 1:10 dilution of a monoclonal antibody specific for Cbfβ (a.a. 1-141) 14 , or a 1:5000 dilution of a polyclonal antibody specific for MEN1 (gift of SC Chandrasekharappa, National Institutes of Health, Bethesda MD); followed by a 
Cell staining and flow cytometry
Peripheral blood was obtained from anaesthetized animals by cardiac puncture. Lineage depletion and cell sorting of bone marrow was performed as described previously 24 using purified antibodies to CD4, CD8, B220, Mac1, GR1, and Ter119
(Caltag Laboratories, Burlingame, CA). Biotinylated c-kit (ACK4-biotin) antibody and streptavidin-PE (BD pharmingen) were used to stain bone marrow cells after lineage depletion. Fetal liver and aorta-gonad-mesonephros (AGM) were dissected from 11.5 and 12.5 dpc embryos using standard techniques. The tissues were dissociated by trituration using a 25-gauge needle and passed through a nylon mesh.
Methylcellulose colony forming assays
Adult bone marrow and 11.5 dpc fetal liver cells were washed and resuspended in Iscoves MDM (Invitrogen) with 10% FBS (StemCell technologies, Vancouver, BC, Canada). Cells were incubated in 35 mm suspension dishes in IMDM containing 0.9% methylcellulose, 15% FBS, 1% bovine serum albumin, 10 ug/ml bovine pancreatic insulin, 200 ug/ml human transferring, 10 -4 M 2-mercaptoethanol, 2 mM L-glutamine, 50 ng/mL rm SCF, 10 ng/ml rm IL-3, 10 ng/ml rm IL-6, and 3 units/ml rh erythropoietin (MethoCult GF M3434 StemCell technologies). Colonies were visualized and counted after 10 days in culture. and Table 2 ) and long-term repopulation assays using 14.5 dpc fetal liver (data not shown). The presence and normal distribution of all mature lineages was confirmed by flow cytometric analysis of 16.5 dpc fetal liver and peripheral blood smear of newborn Cbfb GFP/GFP pups (data not shown). These data suggest that hematopoiesis is relatively normal and does not account for the lethality of the newborn pups.
RESULTS
Generation of the
Cbfβ β is expressed in all of the major hematopoietic tissues in adult mice.
Previous studies have suggested that Cbfb transcripts are expressed ubiquitously in adult mice 11, 12 . In order to evaluate the expression of Cbfβ in various hematopoietic cell populations in adult mice, cells were harvested from several hematopoeitic tissues in
Cbfb-GFP heterozygous animals and analyzed for GFP expression by flow cytometry.
FACS analysis showed a single peak of GFP-expressing cells in the thymus, lymph Figure 2D, lane 1) .
GFP expression analysis in B220 + B-lymphocytes in the bone marrow revealed two populations (see Figure 2E , left panel). The various stages of B-cell differentiation in the bone marrow and corresponding markers are reviewed in 23 . Figure 2E demonstrates that Cbfβ was expressed at high levels in pro-B Figure 2E ) and spleen (data not shown) expressed only low levels of Cbfβ, B220 + cells blood expressed slightly higher levels (data not shown).
The number and percentage of CD4/8 T-cells were normal in the thymus, lymph nodes, and spleen of heterozygote Cbfb-GFP animals, as was the percentage of CD3 + Tlymphocytes in the peripheral blood (data not shown). All of the populations expressed uniform levels of GFP, suggesting that T-lymphocytes express Cbfβ-GFP (data not shown).
Cbfβ β is expressed in hematopoietic stem cells and progenitors.
Because the absence of definitive hematopoiesis in the fetal livers of Cbfb homozygous knock-out embryos suggests an early defect in hematopoietic differentiation, we wanted to determine whether or not Cbfβ is expressed in (Table 1) . It is interesting to note that the greatest enrichment was observed in the CFU-GEM, which originates from a more immature progenitor that gives rise to both erythroid and myeloid cells.
Cbfβ β is expressed in the c-kit hi cells in the embryonic sites of definitive hematopoiesis.
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In order to examine the expression of Cbfβ in embryonic hematopoietic cells, we dissected the major sites of hematopoiesis including the AGM, fetal liver, and yolk sac from 11.5 dpc embryos. The GFP signal in wild type yolk sac cells was indistinguishable from heterozygous and homozygous embryos (data not shown). In the AGM and fetal liver, c-kit marks the hematopoietic stem/progenitor cells. The c-kit hi cells in the AGM at 11.5 dpc comprise 1-2% cells in the AGM, and all of them expressed Cbfβ-GFP ( Figure   4A ). In the fetal liver, the c-kit hi cells included 30-40% of the cells, and again, all expressed Cbfβ-GFP, although in heterozygous animals, the distinction between GFP + and GFP -was not as clear as in the homozygous animals ( Figure 4B ). Nevertheless, sorting the c-kit hi cells from a heterozygous embryo into GFP + and GFP -populations ( Figure 4C ) resulted in a significant enrichment of erythroid (6-7 fold), myeloid (3-4 fold), and mixed (4-5 fold) colony-forming units, suggesting that myeloid and erythroid progenitor cells express high amounts of Cbfβ (Table 2 ).
There was no significant difference in the percentage of c-kit hi cells in the fetal liver and AGM of wild-type, heterozygous, and homozygous embryos ( Figure 4A and 4B); nor was there any significant difference in the colony-forming potential of the fetal livers isolated from these animals ( Table 2 ), suggesting that the hematopoietic stem cells and progenitors in homozygous embryos are intact.
The c-kit hi population of cells is absent from AGM and fetal liver of embryos
expressing Cbfb-MYH11.
Previous studies revealed that heterozygous (Cbfb
+/MYH11
) embryos expressing
Cbfb-MYH11 exhibited a complete absence of definitive hematopoiesis in the fetal liver. To further characterize the defect in these embryos, we examined the expression of c-kit and Cbfβ-GFP in the Cbfb +/MYH11 embryos. In the fetal liver at 11.5 dpc, we found a complete absence of the c-kit hi (CD34-positive and -negative) population suggesting that expression of Cbfb-MYH11 prevented the formation and/or migration of the stem/progenitor cells ( Figure 5A and 5B). There were very few cells expressing Cbfβ- This population of cells was also absent from embryos expressing Cbfb-MYH11 ( Figure   5C ), suggesting that the defect occurs very early in hematopoietic differentiation, prior to migration of hematopoietic stem cells and progenitors from the AGM to the fetal liver. Figure 3B were assessed by methylcellulose colony assay. The table shows the mean and standard deviation of the data collected from three independent experiments (n=3). 5 X 10 4 cells from each population were plated in each culture.
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